Naproxen topical gel - Bayer
Alternative Names: BAY H006689Latest Information Update: 14 Oct 2024
Price :
$50 *
At a glance
- Originator Bayer
- Class Analgesics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Musculoskeletal pain
Most Recent Events
- 20 Aug 2024 Bayer completes a phase I trial for Muscoskeletal pain (In volunteers) in USA (Topical) (NCT06511973)
- 01 Aug 2024 Bayer completes a phase-I trial in Muscoskeletal pain ( (In volunteers) in USA (Topical), (NCT06415019)
- 23 Jul 2024 Bayer initiates a phase I trial for Muscoskeletal pain (In volunteers) in USA (Topical) (NCT06511973)